Amsterdam-based Neurocast has developed a platform that turns routine smartphone use into a neurological data stream.

Sanofi joins a growing chorus of drugmakers boosting their U.S. operations in the face of President Trump's trade policies.

Sanofi expects to add “a significant number of high-paying jobs” in the U.S. with $20 billion investment through 2030.

Oklahoma scientists find interferon-beta may help MS patients on B cell therapy fight infections like flu and Covid-19, new ...

Despite advances in treatment, people with multiple sclerosis (MS) continue to face stark inequalities in care. It’s time to ...

New evidence added to the literature that paramagnetic rim lesions (PRLs) may be a biomarker of disability accumulation in ...

Sanofi is racing to raise the flag on meningitis ... which are to be further showcased at multiple touchpoints throughout the event. The #59 car was unveiled in Paris on April 29 in a ...

Sanofi’s new multiple myeloma drug Sarclisa (isatuximab) has been approved in the EU for relapsed/refractory disease, taking on Johnson & Johnson’s well-established blockbuster Darzalex.

The four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...

WASHINGTON — Selma Blair says she's doing "amazingly well" amid her multiple sclerosis battle. The "Legally Blonde" actress shared her health update while at The Daily Front Row's annual Fashion ...

Discover how acupuncture may provide relief from common multiple sclerosis symptoms, and relevant research on effectiveness. While far from conclusive, some studies indicate acupuncture may be ...

BELLAIRE, Ohio — The state fire marshal has been called in to investigate the cause of a fire Friday afternoon that affected multiple structures on Washington Street in Bellaire. As of 9 p.m ...